Pulmonary Aerosolized Formulation or Nasal Drops containing Recombinant Human Angiotensin converting Enzyme 2 (rhACE2) as a Potential Therapy against COVID-19
المصدر: Research Journal of Pharmacy and Technology · الاستشهادات (Scopus): 5
| الصفحات | 3433-3436 |
|---|---|
| DOI | 10.52711/0974-360X.2021.00597 |
| نوع المنشور | مقالة دورية |
| الفهرسة | Scopus |